Calamos Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Sell
140,846
-2,618
-2% -$211K 0.04% 373
2026
Q1
$10.1M Hold
143,464
0.04% 399
2025
Q4
$11.3M Sell
143,464
-5,825
-4% -$461K 0.04% 361
2025
Q3
$12.3M Hold
149,289
0.05% 364
2025
Q2
$12M Hold
149,289
0.05% 366
2025
Q1
$12M Buy
149,289
+1,663
+1% +$138K 0.05% 353
2024
Q4
$12.1M Hold
147,626
0.05% 360
2024
Q3
$12.2M Sell
147,626
-3,622
-2% -$271K 0.05% 364
2024
Q2
$10.6M Sell
151,248
-5,521
-4% -$394K 0.05% 385
2024
Q1
$11.6M Sell
156,769
-3,943
-2% -$275K 0.06% 363
2023
Q4
$10.6M Sell
160,712
-2,100
-1% -$131K 0.05% 373
2023
Q3
$10.2M Hold
162,812
0.05% 387
2023
Q2
$9.2M Hold
162,812
0.05% 451
2023
Q1
$9.43M Sell
162,812
-20,495
-11% -$1.38M 0.05% 459
2022
Q4
$13.3M Sell
183,307
-32,245
-15% -$2.31M 0.06% 368
2022
Q3
$13.1M Hold
215,552
0.06% 376
2022
Q2
$13.5M Buy
215,552
+5,804
+3% +$384K 0.06% 385
2022
Q1
$14.7M Buy
209,748
+27,958
+15% +$1.89M 0.06% 394
2021
Q4
$11.4M Buy
181,790
+7,038
+4% +$442K 0.04% 449
2021
Q3
$10.8M Buy
174,752
+15,420
+10% +$928K 0.05% 408
2021
Q2
$9.54M Buy
159,332
+36,241
+29% +$2.3M 0.04% 415
2021
Q1
$7.48M Buy
123,091
+3,804
+3% +$210K 0.04% 411
2020
Q4
$5.6M Sell
119,287
-5,166
-4% -$224K 0.03% 475
2020
Q3
$4.63M Sell
124,453
-10,923
-8% -$415K 0.03% 469
2020
Q2
$4.94M Sell
135,376
-8,663
-6% -$302K 0.03% 447
2020
Q1
$4.4M Sell
144,039
-12,303
-8% -$546K 0.03% 422
2019
Q4
$7.97M Sell
156,342
-2,817
-2% -$136K 0.04% 410
2019
Q3
$7.51M Buy
159,159
+13,798
+9% +$658K 0.04% 420
2019
Q2
$7.22M Sell
145,361
-191,810
-57% -$9.02M 0.04% 423
2019
Q1
$14.4M Sell
337,171
-23,349
-6% -$1.03M 0.09% 259
2018
Q4
$14.8M Buy
360,520
+22,140
+7% +$950K 0.1% 252
2018
Q3
$15.8M Buy
338,380
+8,949
+3% +$409K 0.09% 253
2018
Q2
$14.4M Sell
329,431
-223,399
-40% -$10.4M 0.09% 273
2018
Q1
$25.4M Buy
552,830
+7,415
+1% +$360K 0.17% 178
2017
Q4
$27.6M Sell
545,415
-88,960
-14% -$4.69M 0.14% 160
2017
Q3
$33M Sell
634,375
-74,208
-10% -$3.61M 0.25% 119
2017
Q2
$34.7M Buy
708,583
+5,194
+0.7% +$241K 0.26% 110
2017
Q1
$33.1M Sell
703,389
-7,946
-1% -$379K 0.26% 107
2016
Q4
$34.2M Sell
711,335
-388,857
-35% -$17.8M 0.27% 110
2016
Q3
$43.6M Sell
1,100,192
-12,029
-1% -$452K 0.31% 92
2016
Q2
$39.5M Sell
1,112,221
-749
-0.1% -$29.2K 0.28% 112
2016
Q1
$43.6M Buy
1,112,970
+11,219
+1% +$419K 0.29% 108
2015
Q4
$47.3M Sell
1,101,751
-19
-0% -$836 0.3% 101
2015
Q3
$46.3M Sell
1,101,770
-540
-0% -$25.2K 0.32% 96
2015
Q2
$55M Sell
1,102,310
-694,325
-39% -$32.9M 0.34% 89
2015
Q1
$80.9M Sell
1,796,635
-333,871
-16% -$15M 0.51% 51
2014
Q4
$103M Buy
2,130,506
+1,941,741
+1,029% +$92.3M 0.68% 31
2014
Q3
$9.04M Hold
188,765
0.06% 268
2014
Q2
$9.35M Buy
188,765
+13,576
+8% +$635K 0.06% 257
2014
Q1
$8.24M Hold
175,189
0.05% 264
2013
Q4
$8.42M Sell
175,189
-715,651
-80% -$32.1M 0.05% 258
2013
Q3
$37.3M Buy
890,840
+372,543
+72% +$16.1M 0.23% 113
2013
Q2
$21.1M Buy
+518,297
New +$19.1M 0.14% 164

Other funds holding MET

Calamos Advisors's MET Position: Q2 2026 in Review

Calamos Advisors reduced its MetLife (MET) stake by 1.8% in Q2 2026, selling an estimated $211K and leaving 140,846 shares worth $11.9M. The position accounts for 0.04% of the portfolio, ranked #373.

Calamos Advisors first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $103M in Q4 2014. 865 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Calamos Advisors held 140,846 shares of MetLife worth $11.9M as of Q2 2026.
  • Calamos Advisors sold 2,618 MetLife shares in Q2 2026, an estimated $211K.
  • MetLife made up 0.04% of Calamos Advisors's portfolio in Q2 2026, its #373 holding.
  • Calamos Advisors first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Calamos Advisors's MetLife position peaked at $103M in Q4 2014.
  • 865 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.